Vycor Medical (VYCO) Common Equity (2010 - 2026)
Vycor Medical (VYCO) reported Common Equity of -$4.2 million for Q1 2026, down 8.69% year-over-year from -$4.6 million in Q1 2025, and down 3.48% on a QoQ basis from -$4.1 million in Q4 2025.
Vycor Medical (VYCO) has 17 years of Common Equity data on file, last reported at -$4.2 million in Q1 2026.
- Quarterly Common Equity fell 8.69% year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.2 million (down 8.69% YoY) and the FY2025 annual result came in at -$4.1 million, down 10.75% from the prior year.
- Common Equity fell to -$4.2 million in Q1 2026 per VYCO's latest filing, from -$4.1 million in the prior quarter.
- Across five years, Common Equity topped out at -$2.6 million in Q1 2022 and bottomed at -$4.2 million in Q1 2026.
- The 5-year median for Common Equity is -$3.5 million (2024), against an average of -$3.4 million.
- The widest annual swing landed in 2022, when Common Equity slumped 222.78%; it then fell 8.69% in 2026.
- Tracing VYCO's Common Equity over 5 years: stood at -$2.9 million in 2022, then fell by 13.08% to -$3.3 million in 2023, then declined by 10.96% to -$3.7 million in 2024, then fell by 10.75% to -$4.1 million in 2025, then declined by 3.48% to -$4.2 million in 2026.
- Per Business Quant, the three latest VYCO Common Equity figures stand at -$4.2 million (Q1 2026), -$4.1 million (Q4 2025), and -$4.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | -4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.23 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | -3.87 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -3.69 Mn |
| Sep 30, 2024 | -3.68 Mn |
| Jun 30, 2024 | -3.53 Mn |
| Mar 31, 2024 | -3.52 Mn |
| Dec 31, 2023 | -3.33 Mn |
| Sep 30, 2023 | -3.23 Mn |
| Jun 30, 2023 | -3.02 Mn |
| Mar 31, 2023 | -3.10 Mn |
| Dec 31, 2022 | -2.94 Mn |
| Sep 30, 2022 | -2.82 Mn |
| Jun 30, 2022 | -2.60 Mn |
| Mar 31, 2022 | -2.59 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | -2.26 Mn |
| Jun 30, 2021 | -2.18 Mn |
| Mar 31, 2021 | -2.26 Mn |
| Dec 31, 2020 | -1.98 Mn |
| Sep 30, 2020 | -1.91 Mn |
| Jun 30, 2020 | -1.67 Mn |
| Mar 31, 2020 | -1.56 Mn |
| Dec 31, 2019 | -1.35 Mn |
| Sep 30, 2019 | -1.27 Mn |
| Jun 30, 2019 | -1.03 Mn |
| Mar 31, 2019 | -977,816.00 |
| Dec 31, 2018 | -768,827.00 |
| Sep 30, 2018 | -419,887.00 |
| Jun 30, 2018 | -239,833.00 |
| Mar 31, 2018 | -290,172.00 |
| Dec 31, 2017 | 81,442.00 |
| Sep 30, 2017 | 411,896.00 |
| Jun 30, 2017 | 853,983.00 |
| Mar 31, 2017 | 750,839.00 |
| Dec 31, 2016 | -26,438.00 |
| Sep 30, 2016 | 399,144.00 |
| Jun 30, 2016 | 657,827.00 |
| Mar 31, 2016 | 872,920.00 |
| Dec 31, 2015 | 1.26 Mn |
| Mar 31, 2015 | 2.36 Mn |
| Dec 31, 2014 | 3.61 Mn |
| Sep 30, 2014 | 3.43 Mn |
| Jun 30, 2014 | 1.49 Mn |
| Mar 31, 2014 | -247,332.00 |
| Sep 30, 2013 | -2.82 Mn |
| Jun 30, 2013 | -2.41 Mn |
| Mar 31, 2013 | -2.08 Mn |
| Dec 31, 2012 | -1.46 Mn |
| Sep 30, 2012 | -1.17 Mn |
| Jun 30, 2012 | -445,847.00 |
| Mar 31, 2012 | 383,410.00 |
| Dec 31, 2011 | 875,324.00 |
| Sep 30, 2011 | 1.74 Mn |
| Jun 30, 2011 | 1.94 Mn |
| Dec 31, 2010 | 88,714.00 |